CH1701 for Prevention and Treatment of Radiation Burns
A combined Phase I\&II, randomized, double-blind, placebo-controlled clinical trial to evaluate efficacy and safety for prevention and treatment of radiation therapy burn of CH1701
Cancer
DRUG: CH1701 for prevention and treatment of radiation burns.|DRUG: Safety assessment of CH1701|DRUG: Placebos
Side effects by skin biopsy, Skin biopsy after 14 days of topical application, compared with healthy skin, 14 days|Degree of burns according to CTCAE 4.03 atlas, Take photograph of skin every week comparing with atlas CTCAE 4.03 to determine the degree of burns, 63 days
A combined Phase I\&II, randomized, double-blind, placebo-controlled clinical trial to evaluate efficacy and safety for prevention and treatment of radiation therapy burn of CH1701